Chinese Journal of Stroke ›› 2023, Vol. 18 ›› Issue (01): 107-113.DOI: 10.3969/j.issn.1673-5765.2023.01.012
Previous Articles Next Articles
Received:
2022-07-28
Online:
2023-01-20
Published:
2023-01-20
段春苗, 熊云云, 王拥军
通讯作者:
王拥军 yongjunwang@ncrcnd.org.cn
基金资助:
DUAN Chunmiao, XIONG Yunyun, WANG Yongjun. Thrombolysis or Not Thrombolysis for Minor Stroke?[J]. Chinese Journal of Stroke, 2023, 18(01): 107-113.
段春苗, 熊云云, 王拥军. 轻型卒中:溶栓还是不溶栓?[J]. 中国卒中杂志, 2023, 18(01): 107-113.
[1] WANG Y J,LI Z X,GU H Q,et al. China stroke statistics:an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases,China National Clinical Research Center for Neurological Diseases,the Chinese Stroke Association,National Center for Chronic and Non-communicable Disease Control and Prevention,Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations[J]. Stroke Vasc Neurol,2022,7(5):415-450. [2] DHAMOON M S,MOON Y P,PAIK M C,et al. Long-term functional recovery after first ischemic stroke:the Northern Manhattan study[J]. Stroke,2009,40(8):2805-2811. [3] REEVES M,KHOURY J,ALWELL K,et al. Distribution of national institutes of health stroke scale in the Cincinnati/Northern Kentucky stroke study[J]. Stroke,2013,44(11):3211-3213. [4] LI Z X,WANG C J,ZHAO X Q,et al. Substantial progress yet significant opportunity for improvement in stroke care in China[J]. Stroke,2016,47(11):2843-2849. [5] LI L,PAN Y S,WANG M X,et al. Trends and predictors of myocardial infarction or vascular death after ischaemic stroke or TIA in China,2007-2018:insights from China national stroke registries[J]. Stroke Vasc Neurol,2021,6(2):214-221. [6] KLEINDORFER D O,TOWFIGHI A,CHATURVEDI S,et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack:a guideline from the American Heart Association/American Stroke Association[J/OL]. Stroke,2021,52(7):e364-e467[2022-07-22]. https://doi.org/10.1161/STR.0000000000000375. [7] KIRCHHOF P,BENUSSI S,KOTECHA D,et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Eur Heart J,2016,37(38):2893-2962. [8] SMITH E E,FONAROW G C,REEVES M J,et al. Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator:findings from get with the guidelines-stroke[J]. Stroke,2011,42(11):3110-3115. [9] ROMANO J G,GARDENER H,CAMPO-BUSTILLO I,et al. Predictors of outcomes in patients with mild ischemic stroke symptoms:MaRISS[J]. Stroke,2021,52(6):1995-2004. [10] TAN Y,PAN Y S,LIU L P,et al. One-year outcomes and secondary prevention in patients after acute minor stroke:results from the China national stroke registry[J]. Neurol Res,2017,39(6):484-491. [11] EMBERSON J,LEES K R,LYDEN P,et al. Effect of treatment delay,age,and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke:a meta-analysis of individual patient data from randomised trials[J]. Lancet,2014,384(9958):1929-1935. [12] MA H,CAMPBELL B C V,PARSONS M W,et al. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke[J]. N Engl J Med,2019,380(19):1795-1803. [13] SABER H,KHATIBI K,SZEDER V,et al. Reperfusion therapy frequency and outcomes in mild ischemic stroke in the United States[J]. Stroke,2020,51(11):3241-3249. [14] XIONG Y Y,YAN R,GU H Q,et al. Intravenous thrombolysis in Chinese patients with mild acute ischemic stroke[J/OL]. Ann Transl Med,2021,9(9):767[2022-07-02]. https://doi.org/10.21037/atm-21-40. [15] ASDAGHI N,WANG K,CILIBERTI-VARGAS M A,et al. Predictors of thrombolysis administration in mild stroke:florida-puerto rico collaboration to reduce stroke disparities[J]. Stroke,2018,49(3):638-645. [16] HARBISON J W. Ticlopidine versus aspirin for the prevention of recurrent stroke. Analysis of patients with minor stroke from the ticlopidine aspirin stroke study[J]. Stroke,1992,23(12):1723-1727. [17] NORRVING B,CRONQVIST S. Clinical and radiologic features of lacunar versus nonlacunar minor stroke[J]. Stroke,1989,20(1):59-64. [18] OLSSON J E,MÜLLER R,BERNELI S. Long-term anticoagulant therapy for TIAs and minor strokes with minimum residuum[J]. Stroke,1976,7(5):444-451. [19] FISCHER U,BAUMGARTNER A,ARNOLD M,et al. What is a minor stroke?[J]. Stroke,2010,41(4):661-666. [20] POST P N,STIGGELBOUT A M,WAKKER P P. The utility of health states after stroke:a systematic review of the literature[J]. Stroke,2001,32(6):1425-1429. [21] CRESPI V,BRAGA M,BERETTA S,et al. A practical definition of minor stroke[J]. Neurol Sci,2013,34(7):1083-1086. [22] KHATRI P,CONAWAY M R,JOHNSTON K C,et al. Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke[J]. Stroke,2012,43(2):560-562. [23] ROMANO J G,SMITH E E,LIANG L,et al. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis:a retrospective analysis of the get with the guidelines-stroke registry[J]. JAMA Neurol,2015,72(4):423-431. [24] JOHNSTON S C,AMARENCO P,ALBERS G W,et al. Ticagrelor versus aspirin in acute stroke or transient ischemic attack[J]. N Engl J Med,2016,375(1):35-43. [25] JOHNSTON S C,AMARENCO P,DENISON H,et al. Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA[J]. N Engl J Med,2020,383(3):207-217. [26] WANG Y J,WANG Y L,ZHAO X Q,et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack[J]. N Engl J Med,2013,369(1):11-19. [27] WANG Y J,MENG X,WANG A X,et al. Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA[J]. N Engl J Med,2021,385(27):2520-2530. [28] JOHNSTON S C,EASTON J D,FARRANT M,et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA[J]. N Engl J Med,2018,379(3):215-225. [29] XIONG Y Y,GU H Q,ZHAO X Q,et al. Clinical characteristics and in-hospital outcomes of varying definitions of minor stroke:from a large-scale nation-wide longitudinal registry[J]. Stroke,2021,52(4):1253-1258. [30] TORRES-MOZQUEDA F,HE J,YEH I B,et al. An acute ischemic stroke classification instrument that includes CT or MR angiography:the Boston acute stroke imaging scale[J]. AJNR Am J Neuroradiol,2008,29(6):1111-1117. [31] National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group. Recombinant tissue plasminogen activator for minor strokes:the National Institute of Neurological Disorders and Stroke rt-PA stroke study experience[J]. Ann Emerg Med,2005,46(3):243-252. [32] KHATRI P,TAYAMA D,COHEN G,et al. Effect of intravenous recombinant tissue-type plasminogen activator in patients with mild stroke in the third international stroke trial-3:post hoc analysis[J]. Stroke,2015,46(8):2325-2327. [33] CHOI J C,JANG M U,KANG K,et al. Comparative effectiveness of standard care with Ⅳ thrombolysis versus without Ⅳ thrombolysis for mild ischemic stroke[J/OL]. J Am Heart Assoc,2015,4(1):e001306[2022-07-02]. https://doi.org/10.1161/JAHA.114.000596. [34] KHATRI P,KLEINDORFER D O,DEVLIN T,et al. Effect of alteplase vs aspirin on functional outcome for patients with acute ischemic stroke and minor nondisabling neurologic deficits:the PRISMS randomized clinical trial[J]. JAMA,2018,320(2):156-166. [35] POWERS W J,RABINSTEIN A A,ACKERSON T,et al. Guidelines for the early management of patients with acute ischemic stroke:2019 update to the 2018 guidelines for the early management of acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J/OL]. Stroke,2019,50(12):e344-e418[2022-07-02]. https://doi.org/10.1161/STR.0000000000000211. [36] BERGE E,WHITELEY W,AUDEBERT H,et al. European Stroke Organisation(ESO)guidelines on intravenous thrombolysis for acute ischaemic stroke[J/OL]. Eur Stroke J,2021,6(1):I-LXII[2022-07-02]. https://doi.org/10.1177/2396987321989865. [37] 刘丽萍,陈玮琪,段婉莹,等. 中国脑血管病临床管理指南(节选版):缺血性脑血管病临床管理[J]. 中国卒中杂志,2019,14(7):709-726. [38] HELDNER M R,ZUBLER C,MATTLE H P,et al. National institutes of health stroke scale score and vessel occlusion in 2152 patients with acute ischemic stroke[J]. Stroke,2013,44(4):1153-1157. [39] MAZYA M V,COORAY C,LEES K R,et al. Minor stroke due to large artery occlusion. When is intravenous thrombolysis not enough? Results from the SITS international stroke thrombolysis register[J]. Eur Stroke J,2018,3(1):29-38. [40] KIM J T,PARK M S,CHANG J,et al. Proximal arterial occlusion in acute ischemic stroke with low NIHSS scores should not be considered as mild stroke[J/OL]. PLoS One,2013,8(8):e70996[2022-07-02]. https://doi.org/10.1371/journal.pone.0070996. [41] GWAK D S,KWON J A,SHIM D H,et al. Perfusion and diffusion variables predict early neurological deterioration in minor stroke and large vessel occlusion[J]. J Stroke,2021,23(1):61-68. [42] ZHONG W S,ZHOU Y,ZHANG K M,et al. Minor non-disabling stroke patients with large vessel severe stenosis or occlusion might benefit from thrombolysis[J/OL]. Brain Sci,2021,11(7):945[2022-07-02]. https://doi.org/10.3390/brainsci11070945. [43] TSIVGOULIS G,GOYAL N,KATSANOS A H,et al. Intravenous thrombolysis for large vessel or distal occlusions presenting with mild stroke severity[J]. Eur J Neurol,2020,27(6):1039-1047. [44] SENERS P,PERRIN C,LAPERGUE B,et al. Bridging therapy or Ⅳ thrombolysis in minor stroke with large vessel occlusion[J]. Ann Neurol,2020,88(1):160-169. [45] SENERS P,DARGAZANLI C,PIOTIN M,et al. Intended bridging therapy or intravenous thrombolysis alone in minor stroke with basilar artery occlusion[J]. Stroke,2021,52(2):699-702. [46] WU X,KHUNTE M,PAYABVASH S,et al. Outcomes after thrombectomy for minor stroke:a meta-analysis[J/OL]. World Neurosurg,2021,149:e1140-e1154[2022-07-02]. https://doi.org/10.1016/j.wneu.2020.12.047. [47] FEIL K,MATUSEVICIUS M,HERZBERG M,et al. Minor stroke in large vessel occlusion:a matched analysis of patients from the German stroke registry-endovascular treatment(GSR-ET)and patients from the safe implementation of treatments in stroke-international stroke thrombolysis register(SITS-ISTR)[J]. Eur J Neurol,2022,29(6):1619-1629. [48] SENERS P,ARQUIZAN C,FONTAINE L,et al. Perfusion imaging and clinical outcome in acute minor stroke with large vessel occlusion[J]. Stroke,2022,53(11):3429-3438. [49] KEYT B A,PAONI N F,REFINO C J,et al. A faster-acting and more potent form of tissue plasminogen activator[J]. Proc Natl Acad Sci U S A,1994,91(9):3670-3674. [50] COUTTS S B,DUBUC V,MANDZIA J,et al. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion[J]. Stroke,2015,46(3):769-774. [51] SYKORA M,KREBS S,SIMADER F,et al. Intravenous thrombolysis in stroke with admission NIHSS score 0 or 1[J].Int J Stroke,2022,17(1):109-119. |
[1] | WANG Kaiwen, LU Baoquan, WU Xiuling, MA Jiali. A Novel BAOPS-MRA Score Predicts Outcome in Nonsevere Basilar Artery Occlusion [J]. Chinese Journal of Stroke, 2022, 17(12): 1335-1342. |
[2] | WU Xiaoli, LIU Lixu. The Effect of Obesity on Prognosis of Stroke [J]. Chinese Journal of Stroke, 2022, 17(12): 1391-1395. |
[3] | DENG Yuhan, LIU Shuang, WANG Ziyao, WANG Yuxin, LIU Baohua. The Effect of Machine Learning Model for Predicting Stroke Risk in the General Population Based on Structured Data: A Systematic Review and Meta-Analysis [J]. Chinese Journal of Stroke, 2022, 17(11): 1189-1197. |
[4] | ZHAO Yongrui, LIU Zhanhui. Progress of Diffusion Tensor Imaging in Evaluating Motor Function Prognosis of Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1114-1119. |
[5] | DOU Pengyu, BAN Mengke, GUI Yongkun, BAO Wanli, ZHANG Ping. Association of White Matter Hyperintensities with Clinical Outcome in Patients with Isolated Middle Cerebral Artery Severe Stenosis or Occlusion [J]. Chinese Journal of Stroke, 2022, 17(09): 985-990. |
[6] | WU Qian, TAO Liyuan, CHEN Siqi, ZHONG Lianmei, LIU Liping, MI Donghua. The Impact of Blood Glucose Fluctuation on Delayed Cerebral Ischemia and 30-day Mortality in Aneurysm Subarachnoid Hemorrhage [J]. Chinese Journal of Stroke, 2022, 17(08): 845-850. |
[7] | SONG Xulin, CHEN Laizhao, WEI Minggui. Effect of A2 Segment Configuration of Anterior Cerebral Artery on Clipping of Anterior Communicating Aneurysms via Left Pterional Approach [J]. Chinese Journal of Stroke, 2022, 17(08): 851-856. |
[8] | YANG Jialei, CHEN Siding, MENG Xia, JIANG Yong, WANG Yongjun. Prediction of Clinical Outcome of Acute Ischemic Stroke Patients with Hyperglycemia Based on Machine Learning Model [J]. Chinese Journal of Stroke, 2022, 17(07): 730-736. |
[9] | LIU Yanfang, JIA Jiaokun, ZHAO Xingquan. Risk Factors for Short-term Poor Prognosis in Young Patients with First-ever Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(06): 600-604. |
[10] | YANG Jialei, CHEN Siding, MENG Xia, JIANG Yong, WANG Yongjun. Validity Comparison of Stroke Prognosis Scales in Patients with Anterior or Posterior Circulation Ischemic Strok [J]. Chinese Journal of Stroke, 2022, 17(06): 616-621. |
[11] | SONG Xinjie, WANG Anxin, LI Zixiao, ZHAO Xingquan. Relationship between Deep Vein Thrombosis of the Lower Extremity and Prognosis of Patients with IntracerebralHemorrhage [J]. Chinese Journal of Stroke, 2022, 17(06): 634-637. |
[12] | ZHANG Dong, LI Zhizhang, MA Ruinan, YUE Yunhua. Correlation between Stress Hyperglycemia Ratio and Clinical Prognosis of Patients with Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(05): 483-490. |
[13] | ZHANG Tong, WANG Anxin, AN Yuan, ZHANG Yaqing, LIU Yanfang, ZHAO Xingquan. Meta-analysis of Clinical Outcomes of Treatment for Anterior Circulation Tandem Lesions [J]. Chinese Journal of Stroke, 2022, 17(05): 503-509. |
[14] | CHEN Siding, Yu Weiran, HUANG Xinying, LIU Huan, JIANG Yong, WANG Yongjun. 1-Year Functional Outcome Prediction of New-Onset Acute Ischemic Stroke Patients Based on Machine Learning [J]. Chinese Journal of Stroke, 2022, 17(03): 265-271. |
[15] | LIU Zhong, LIU Yuanyuan, XU Shaofeng, GUO Wei, KANG Hai. Correlation Analysis of Systemic Immune-Inflammatory Index with Severity and Prognosis of Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(03): 285-291. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||